financetom
Market
financetom
/
Market
/
Kratos Defense Stock Is Rising Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kratos Defense Stock Is Rising Monday: What's Going On?
Jun 23, 2025 11:50 AM

Shares of Kratos Defense & Security Solutions Inc. are trading higher Monday following an upwardly revised price target and more bullish outlook from Benchmark.

What To Know: The firm raised its 12-month price target for Kratos Defense to $48 from $40, citing new federal defense funding and rising global tensions that underscore Kratos' relevance in future conflicts.

Benchmark analyst Josh Sullivan highlighted two major developments driving the increased valuation forecast. First, the Senate Armed Services Reconciliation Bill, which includes $270 million in new funding for Marine Corps unmanned combat aircraft programs. Kratos is a key contractor in this space, having worked with the Marines on the Valkyrie drone since 2022 and having recently secured a $35 million expansion contract in January. This funding increase could translate into orders for 30 to 50 new Valkyrie units.

Second, Kratos was awarded a five-year OTA contract for the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 under Task Area 1 in January. The bill also mentions a $400 million expansion to the program, which would put Kratos “well ahead” of expected timelines.

The funding is seen as a fast-track boost to an already sizable award and positions Kratos at the center of U.S. hypersonic weapons testing efforts. This expansion is especially timely as Iran's recent military posturing has highlighted the need for advanced drones, hypersonic systems, and ISR (intelligence, surveillance and reconnaissance) capabilities, all core areas of the Kratos portfolio.

Benchmark now projects 2025 revenue of $1.3 billion and adjusted EBITDA of $118.1 million, with an increase to $160.6 million in 2026. That would represent a 36% year-over-year jump in EBITDA.

Benchmark’s price target of $48 acknowledges a potentially high valuation compared to peers, but the firm believes it’s justified by Kratos’ exposure to next-gen defense tech paired with strong government alignment.

KTOS Price Action: Kratos Defense shares were well off the highs of the session, but still up 1.79% at $43.88 at the time of publication Monday, according to Benzinga Pro.

Read Next:

War, Oil, And S&P 500: Here’s How The Stock Market Behaves In Energy Crises

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investors' Focus Shift to Job Market Data as US Equity Futures Waver Pre-Bell
Investors' Focus Shift to Job Market Data as US Equity Futures Waver Pre-Bell
Dec 3, 2024
08:53 AM EST, 12/03/2024 (MT Newswires) -- US equity futures were flat before Tuesday's opening bell as traders looked ahead to data on October job openings for some color around the country's labor market ahead of Friday's highly anticipated November jobs report. Dow Jones Industrial Average futures flatlined, S&P 500 futures gained 0.05%, and Nasdaq futures were down 0.03%. Market...
Sector Update: Tech
Sector Update: Tech
Dec 3, 2024
08:48 AM EST, 12/03/2024 (MT Newswires) -- Technology stocks were steady pre-bell Tuesday as the Technology Select Sector SPDR Fund (XLK) was slightly lower and the SPDR S&P Semiconductor ETF (XSD) was inactive recently. Zscaler ( ZS ) shares were down more than 6% even after the company reported higher fiscal Q1 non-GAAP earnings and revenue. Separately, the company said...
US STOCKS-Wall St on track for muted open ahead of data, Fed commentary
US STOCKS-Wall St on track for muted open ahead of data, Fed commentary
Dec 3, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Tesla slips after its China-made EV sales drop in Nov * October JOLTS data due at 10 a.m. ET * Futures: Dow down 0.02%, S&P 500 up 0.04%, Nasdaq down 0.05% (Updates before market open) By Shashwat Chauhan and...
Sector Update: Health Care
Sector Update: Health Care
Dec 3, 2024
08:54 AM EST, 12/03/2024 (MT Newswires) -- Health care stocks were steady premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) inactive. Coherus BioSciences ( CHRS ) shares were up past 53% after the company said it has agreed to divest its biosimilar drug Udenyca, which is based on Amgen's ( AMGN )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved